Literature DB >> 29330675

Recognizing conserved non-canonical localization patterns of toll-like receptors in tissues and across species.

Glenn Hamonic1,2, J Alex Pasternak1, Heather L Wilson3,4.   

Abstract

Toll-like receptors (TLR) 1, 2, 4, 5 and 6 were originally characterized as exclusively expressed on the cell surface and TLR 3, 7, 8 and 9 were said to be localized to the endosomes. However, continued research in this area shows that TLR localization may be altered across cell-types, and in response to stimulation, age or disease. Mucosal surfaces must remain tolerant to the commensal flora and thus intracellular or basal lateral localization of TLRs at mucosal surfaces may be necessary to prevent induction of an inflammatory response to commensal flora while still allowing the possibility for the receptors to prime an immune response when a pathogen has crossed the epithelial barrier. Here, we highlight the research specifying 'non-canonical' localization of TLRs in human and animal mucosal tissues and blood-derived cells, while excluding cultured polarized immortalized cells. Reports that only indicate TLR gene/protein expression and/or responsiveness to agonists have been excluded unless the report also indicates surface/intracellular distribution in the cell. Understanding the tissue- and species-specific localization of these specific pattern recognition receptors will lead to a greater appreciation of the way in which TLR ligands promote innate immunity and influence the adaptive immune response. A more comprehensive understanding of this information will potentially aid in the exploitation of the therapeutic or adjuvant potential of selectively localized TLRs and in opening new perspectives in understanding the basis of immunity.

Entities:  

Keywords:  Epithelial; Innate immunity; Localization; Mucosal; Toll-like receptor

Mesh:

Substances:

Year:  2018        PMID: 29330675     DOI: 10.1007/s00441-017-2767-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  7 in total

Review 1.  Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

Authors:  Elisha Segrist; Sara Cherry
Journal:  Cell Host Microbe       Date:  2020-03-11       Impact factor: 21.023

2.  Toll-like Receptors for the Treatment of Autoimmune, Inflammation, and Infectious Diseases.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2018-03-16       Impact factor: 4.345

Review 3.  Toll-Like Receptors: Regulators of the Immune Response in the Human Gut.

Authors:  Hubert Hug; M Hasan Mohajeri; Giorgio La Fata
Journal:  Nutrients       Date:  2018-02-13       Impact factor: 5.717

4.  Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.

Authors:  Miia Ruuskanen; Ilmo Leivo; Heikki Minn; Tero Vahlberg; Caj Haglund; Jaana Hagström; Heikki Irjala
Journal:  BMC Cancer       Date:  2019-06-25       Impact factor: 4.430

Review 5.  Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.

Authors:  V Kumar
Journal:  Int Immunopharmacol       Date:  2020-10-12       Impact factor: 4.932

6.  HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis.

Authors:  Xiaoyu Xie; Huanran Lv; Chenxi Liu; Xiaonan Su; Zhen Yu; Shouyang Song; Hongjun Bian; Miaomiao Tian; Chengyong Qin; Jianni Qi; Qiang Zhu
Journal:  BMC Med       Date:  2021-10-15       Impact factor: 8.775

7.  Assessment of Immunological Response and Impacts on Fertility Following Intrauterine Vaccination Delivered to Swine in an Artificial Insemination Dose.

Authors:  Glenn Hamonic; J Alex Pasternak; Siew Hon Ng; Kezia R Fourie; Olena M Simko; Brodie Deluco; Heather L Wilson
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.